TARBP2 and breast cancer: However, the Kaplan–Meier (KM) plot analysis revealed that ZC3H12A is a favorable marker for the prognosis of patients with breast cancer (Figure 4C), which may counteract the mechanism of TARBP2-mediated deubiquitination of HIF-1α.